BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 214 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $347,600 | +15.0% | 5,500 | -18.1% | 0.08% | +11.1% |
| Q1 2023 | $302,153 | +16.4% | 6,716 | +13.3% | 0.07% | +12.5% |
| Q4 2022 | $259,662 | -37.3% | 5,927 | -5.7% | 0.06% | -39.0% |
| Q3 2022 | $414,000 | +22.5% | 6,284 | -6.0% | 0.10% | +31.2% |
| Q2 2022 | $338,000 | -32.7% | 6,687 | -15.0% | 0.08% | -14.0% |
| Q1 2022 | $502,000 | -23.2% | 7,865 | +28.7% | 0.09% | -15.5% |
| Q4 2021 | $654,000 | +6.2% | 6,110 | +2.0% | 0.11% | 0.0% |
| Q3 2021 | $616,000 | +40.6% | 5,989 | +20.4% | 0.11% | +35.8% |
| Q2 2021 | $438,000 | +21.7% | 4,975 | +34.3% | 0.08% | +9.5% |
| Q1 2021 | $360,000 | +37.4% | 3,704 | +58.8% | 0.07% | +37.0% |
| Q4 2020 | $262,000 | +15.9% | 2,333 | -4.5% | 0.05% | +5.9% |
| Q3 2020 | $226,000 | – | 2,443 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |